PATENT CLAIM ANALYSIS

Application Number: 16028558
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "452000"]

Abstract:
The present invention provides a pharmaceutical formulation comprising clomipramine or its pharmaceutically acceptable salt (preferably, clomipramine hydrochloride) as the first active ingredient, and sildenafil or its pharmaceutically acceptable salt (preferably, sildenafil citrate) as the second active ingredient, wherein stability of clomipramine is improved, and a method for manufacturing this pharmaceutical formulation. In particular, the present invention provides a pharmaceutical formulation comprising the above two active ingredients and manufactured by using a wet granulation method, wherein stability of clomipramine is improved, and a method for manufacturing this pharmaceutical formulation.

Claim (Index 23):
The method of  claim 22 , wherein the granule comprising the clomipramine or its pharmaceutically acceptable salt comprises mannitol as an excipient.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 95.0
- Lexical Diversity: 2.125
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15109198', '16330337', '10091559', '15309620', '12449256']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7091159248224198
- 35 USC 102 Novelty (BERT): 0.5574499287226705
- Combined Prediction Score: 0.6939493252124449
- Mean Citation Score: 248.019912
- Max Citation Score: 440.92517
- Similarity Product: 343.9066922701717

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test